abrdn plc - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
abrdn plc ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$31,775,080
-17.2%
841,947
-0.0%
0.08%
-9.0%
Q2 2023$38,370,997
+15.5%
842,208
+2.8%
0.09%
+7.2%
Q1 2023$33,220,993
-31.9%
819,058
-14.4%
0.08%
-37.6%
Q4 2022$48,759,330
+2.1%
956,628
+7.9%
0.13%
-6.3%
Q3 2022$47,757,000
-66.3%
886,711
-59.3%
0.14%
-68.2%
Q2 2022$141,761,000
-16.9%
2,179,922
+0.6%
0.45%
+2.3%
Q1 2022$170,634,000
-11.9%
2,166,241
-4.0%
0.44%
+2.6%
Q4 2021$193,694,000
+5.2%
2,256,458
-0.0%
0.42%
+2.4%
Q3 2021$184,146,000
+8.2%
2,257,530
+6.7%
0.42%
+11.3%
Q2 2021$170,268,000
-12.0%
2,115,123
-7.8%
0.37%
-15.2%
Q1 2021$193,501,000
+0.1%
2,294,028
-4.8%
0.44%
-6.6%
Q4 2020$193,404,000
-13.7%
2,410,319
-13.5%
0.47%
-21.2%
Q3 2020$224,038,000
-7.9%
2,785,852
-1.3%
0.60%
-9.1%
Q2 2020$243,127,000
-11.8%
2,823,764
-16.8%
0.66%
-24.8%
Q1 2020$275,546,000
-15.3%
3,393,850
-12.8%
0.88%
+11.3%
Q4 2019$325,437,000
-0.6%
3,891,832
+4.0%
0.79%
-3.8%
Q3 2019$327,457,000
-13.2%
3,743,649
-18.7%
0.82%
-2.5%
Q2 2019$377,278,000
+1.1%
4,606,567
+0.4%
0.84%
+3.6%
Q1 2019$373,245,000
+9.1%
4,588,974
-12.0%
0.81%
-0.4%
Q4 2018$342,147,000
-22.7%
5,214,462
-9.2%
0.81%
-1.6%
Q3 2018$442,813,000
+130.9%
5,743,738
+121.2%
0.82%
+124.2%
Q2 2018$191,753,000
+101.2%
2,596,870
+77.2%
0.37%
+94.7%
Q1 2018$95,294,000
-2.3%
1,465,179
-2.9%
0.19%
+1.1%
Q4 2017$97,544,000
+2.8%
1,508,904
-0.2%
0.19%
+8.1%
Q3 2017$94,867,0001,511,8240.17%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders